DHR - DANAHER CORP /DE/


198.8
3.300   1.660%

Share volume: 3,522,024
Last Updated: 03-09-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: 0.04%

PREVIOUS CLOSE
CHG
CHG%

$195.50
3.30
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 44%
Dept financing 43%
Liquidity 41%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
-1.58%
1 Month
-9.53%
3 Months
-13.72%
6 Months
3.22%
1 Year
-3.13%
2 Year
-21.36%
Key data
Stock price
$198.80
P/E Ratio 
44.74
DAY RANGE
$193.39 - $199.38
EPS 
$5.07
52 WEEK RANGE
$171.00 - $242.80
52 WEEK CHANGE
-$3.31
MARKET CAP 
161.698 B
YIELD 
0.56%
SHARES OUTSTANDING 
707.139 M
DIVIDEND
$0.40
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,884,648
AVERAGE 30 VOLUME 
$4,267,099
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 1987
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news